Influenza Vaccines: Designs and Developments

Influenza vaccines are vaccines that protect against influenza. During this time, influenza viruses are circulating at higher levels in the U.S. population. An annual seasonal influenza vaccine (either the influenza shot or the nasal spray influenza vaccine) is the best way to reduce the chances that you will get seasonal influenza and spread it to others. When more people get vaccinated against the influenza, less influenza can spread through that community.  Influenza vaccines cause antibodies to develop in the body about two weeks after vaccination. These antibodies provide protection against infection with the viruses that are in the vaccine.

There are two different types of influenza  vaccines, trivalent and quadrivalent. Trivalent vaccines protect against two influenza A viruses (an H1N1 and an H3N2) and an influenza B virus. Quadivalent vaccines protect against two influenza A viruses and two influenza B viruses. Flu vaccines are available either as : a trivalent or quadrivalent injection, which contains the inactivated form of the virus Or a nasal spray of live attenuated influenza vaccine (LAIV, Q/LAIV), which contains the attenuated or weakened form of the virus

  • Universal influenza vaccines
  • Potential application of adjuvants to future vaccines
  • Formulation and delivery methods for vaccines
  • New biomarkers for vaccine response
  • Challenges in vaccinology
  • Immune response towards influenza vaccines
  • Vaccinomics

Related Conference of Influenza Vaccines: Designs and Developments

Influenza Vaccines: Designs and Developments Conference Speakers